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Take home message: This study provides reference values for nitrogen multiple breath washout 
outcomes in healthy Caucasian children from six to 18 years old, measured with a commercialy 
available device. 
 
Keywords: reference values, children, multiple breath washout, lung clearance index, functional 






Background: The nitrogen multiple breath washout (N2MBW) technique is increasingly used to 
assess the degree of ventilation inhomogeneity in school-aged children with lung disease. However, 
reference values for healthy children are currently not available. The aim of this study was to generate 
reference values for N2MBW outcomes in a cohort of healthy Caucasian school-aged children. 
 
Methods: N2MBW data from healthy Caucasian school-age children between 6 and 18 years were 
collected from four experienced centers. Measurements were performed using an ultrasonic flowmeter 
(Exhalyzer D, Eco Medics AG, Duernten, Switzerland) and were analyzed with commercial software 
(Spiroware, 3.2.1, Eco Medics AG). Normative values and upper limits of normal were generated for 
lung clearance index at 2.5% (LCI2.5%) and at 5% (LCI5%), moment ratios (M1/M0 and M2/M0), and a 
prediction equation generated for functional residual capacity (FRC). 
 
Results: Four hundred and eighty five trials from 180 healthy Caucasian children aged from 6 to 18 
years were used for analysis. While LCI increased with age, this increase was negligible (0.04 
units/year for LCI2.5%) and therefore fixed upper limits of normal were defined for this age group. 
These limits were 7.91 for LCI2.5%, 5.73 for LCI5%, 1.75 for M1/M0, and 6.15 for M2/M0 respectively. 
Height and weight were found to be independent predictors of FRC. 
 
Conclusion: We report reference values for N2MBW outcomes measured on a commercially available 
ultrasonic flowmeter device (Exhalyzer D, Eco Medics AG, Duernten, Switzerland) in healthy school-





The multiple breath washout (MBW) test provides lung volume and ventilation distribution outcomes 
that are more sensitive than conventional lung function outcomes to detect lung disease in children 
with cystic fibrosis (CF) [1-3] and potentially other respiratory disorders [4, 5]. The lung clearance 
index (LCI) is a global marker of ventilation distribution derived from the MBW that is reproducible 
[6, 7], discriminates between health and disease [3], and correlates with the extent of structural lung 
disease [2, 8] in children with CF. These data have led to LCI being used as the primary endpoint in 
observational studies and interventional trials in patients with CF [9-11], and potentially as a future 
factor for the clinical surveillance of children with CF [12].  
 
LCI is traditionally calculated as the number of lung turnovers required to washout a tracer gas to 
1/40th (LCI2.5%) of the starting tracer gas concentration [13]. The LCI5% can also be calculated as the 
number of lung turnovers required to washout a tracer gas to 1/20th of the initial tracer gas 
concentration [14, 15]. Moment ratios (M1/M0 and M2/M0) describe the degree of skewness of the 
washout curve and may be more sensitive to detect ventilation inhomogeneity in the periphery of the 
lung [2, 15]. In addition, the MBW test measures the functional residual capacity (FRC) of the lung 
which may indicate some degree of lung hyperinflation [1]. 
 
Despite the increasing use of MBW, reference values for MBW outcomes in children are scarce [16, 
17]. Several commercially available and custom-made MBW devices are currently in use but 
outcomes are generally not interchangeable between them [18-20]. In addition, different software 
versions and system settings can influence the calculation of MBW outcomes [21, 22]. As a result, 
published normative values are only applicable for the specific device, software, and tracer gas used 
[17, 21, 23]. For this reason, studies evaluating MBW outcomes using commercially available 
equipment have required data collection in age-matched healthy controls [2, 12]. 
 
The aim of our study was to provide normative values for nitrogen MBW (N2MBW) outcomes (LCI, 
moment ratios, FRC) measured with a commercially available device using the ultrasonic flowmeter 
 
 
(Exhalyzer D, Eco Medics AG, Duernten, Switzerland) in school-aged children, and to investigate the 
association of MBW outcomes with anthropometric and physiological parameters, including the tidal 
volume and the equipment related dead space volume [24, 25]. To achieve this, we collected data from 
healthy children measured in four different centers with the same MBW device, protocol, and analysed 




For this study we used MBW measurements from healthy school-aged Caucasian children collected 
between 2011 and 2016 from four pediatric centers specialized in N2MBW, including Inselspital, Bern 
(Switzerland), SickKids, Toronto (Canada), University Children’s Hospital, Heidelberg (Germany), 
and Telethon Kids Institute, Perth (Australia). We used the following exclusion criteria: non-
Caucasians, age younger than 6 years or older than 18 years, chronic respiratory or cardiac disease, 
respiratory infection during the last four weeks prior to measurement, and other major systemic 
diseases with potential influence on lung function [26]. Healthy individuals from each center took part 
in prospective observational studies and therefore some data have been published previously [2, 8, 12, 
18, 27, 28]. The study was approved from local ethic committees (Ethics Committee of the Canton of 
Bern, Switzerland, Research Ethics Board at SickKids Toronto, Canada, Ethics Committee of the 
University of Heidelberg, Germany, Princess Margaret Hospital Human Ethics Committee, Perth). 
Parents or caregivers provided informed written consent. 
 
MBW measurements 
We performed N2MBW measurements using the ultrasonic flowmeter (Exhalyzer D, Eco Medics AG, 
Duernten, Switzerland) and the software provided by the manufacturer (Spiroware 3.1.6) as previously 
described [12, 18]. All centers used the same equipment and performed the calibration and 






N2MBW data originally recorded in Spiroware 3.1.6 were reloaded and analyzed using the updated 
version of the software provided by the manufacturer at the time the study was performed (Spiroware 
3.2.1, Eco Medics AG). Further details are provided in the online supplement.  
 
MBW outcomes and physiological indices  
FRC, LCI2.5%, LCI5%, and moment ratios (M1/M0 and M2/M0) were calculated according to current 
recommendations [13, 14]. The mean tidal volume (VT) for each trial was provided by the software. In 
order to investigate the effect of breathing pattern [29] and equipment related dead space (Vd) [30] on 
MBW outcomes, the mean ratio of VT to FRC (VT/FRC, %), and Vd to VT (Vd/VT, %) were calculated 
per trial. 
 
Quality control of MBW trials 
Quality control of MBW trials was assessed by an experienced operator at the Inselspital, Bern (PA), 
according to the 2013 ATS/ERS MBW consensus guidelines and additional criteria proposed by 
Jensen and colleagues [13, 31]. Further details are provided in the online supplement. Tests with at 




Statistical analysis of the data was performed using R (version 3.4.3; R Foundation, Vienna, Austria) 
and Stata (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp 
LP). Graphs were generated using GraphPad Prism (version 5.0; GraphPad Software, San Diego 
California, USA). Normality of data distribution was assessed visually and using the Shapiro-Wilk 
test. The upper and lower limits of normal (ULN and LLN, respectively) correspond to the 97.5th 
centile (mean ± 1.96SD), as previously described [17]. The intra-subject variability was defined as the 
mean relative difference for subjects with two trials [trial1-trial2/mean (%)] or the coefficient of 
variation [CV=SD/mean (%)] for those with at least three trials. We used one-way ANOVA tests with 
 
 
Bonferroni post-hoc test for between-center comparisons. Multiple linear regression was performed to 
assess the associations of normally distributed primary outcomes (LCI2.5%, LCI5%, M1/M0, M2/M0 and 
FRC) with demographic (age, weight, height, sex) and physiological factors (VT/FRC, Vd/VT). All of 
the variables considered were selected for biological reasons. Multicollinearity between independent 
variables was assessed by checking the variance inflation factor and was not present in the final 
models. The homoscedasticity and normality of residuals for the models were assessed using White’s 
test and Shapiro-Wilk test, respectively. In the final models, only significant factors were considered 
to facilitate easy application of the reference equations. The statistical significance level was set to a p-




N2MBW data from 285 healthy children were assessed for eligibility. Of them, 67 did not fulfil the 
inclusion criteria and 38 did not pass the quality control (success rate 82.6%) (Figure 1). Thus, 485 
MBW trials from 180 children were used for analysis: 82 children from the University Children’s 
Hospital in Bern, Switzerland (mean age 10.8 years, range 6.0 -17.8), 33 children from the University 
Children’s Hospital Heidelberg, Germany (mean age 12.0 years, range 7.1 -17.0), 28 children from the 
SickKids in Toronto, Canada (mean age 12.5 years, range 6.5 -17.2) and 37 children from the 
Telethon Kids Institute in Perth, Australia (mean age 9.5 years, range 6.0 -13.6). Of the 180 study 
participants, 38.9% had two acceptable MBW trials, 53.9% had three acceptable trials, and 7.2% had 
four or more acceptable trials.  
 
Center differences 
Study demographics and anthropometrics for each centre are reported in Table 1. Participants from 
Perth were significantly younger compared with those from Toronto and Heidelberg (p < 0.001) 
(Supplemental Figure 1). Participants from Toronto had higher height z-scores compared with those 
from Heidelberg (p = 0.02) but there were no differences in weight z-score between centres. There 
were no differences in LCI or moment ratio outcomes between centers. There were significant 
 
 
differences in FRC (L), whereby children from Toronto had higher FRC values compared to children 
in Perth (p = 0.02) (Supplemental Figure 1).  
 
Lung clearance index and moment ratios 
In univariable regression analyses, LCI2.5% was negatively associated with height (Coef. -0.005, 95% 
CI -0.0087; -0.0019, p=0.002), weight (Coef. -0.0049, 95% CI -0.0090; -0.0008, p=0.020), and age 
(Coef. -0.0225, 95% CI -0.0421; -0.0030, p=0.024), and positively associated with Vd/VT (Coef. 
0.0258, 95% CI 0.0093; 0.0422, p=0.002). No association was found between LCI2.5% and sex or 
VT/FRC (p > 0.05).  
Similarly, LCI5%  and moment ratio outcomes were negatively associated with height, weight, and age 
(Supplemental Table 1). In addition, Vd/VT and VT/FRC were both negatively associated with age 
(Supplemental Figure 2), and LCI5% and M1/M0 were positively associated with Vd/VT and VT/FRC 
(Supplemental Table 1; Supplemental Figure 2). There was no evidence for associations of LCI5% and 
moment ratios with sex (p > 0.05) (Supplemental Table 1).  
 
In a multivariable regression model age, Vd/VT, and VT/FRC were independently associated with LCI 
and moment ratio outcomes (Supplemental Table 2). However, the regression coefficients for each of 
these independent predictors were small (r  0.10). For LCI2.5% the coefficient for age was 0.04, 
indicating that (after adjusting for Vd/VT and VT/FRC) LCI2.5% would increase by 0.04 (95% CI: 0.01; 
0.07) units per year. This equates to a maximum 0.5 unit change in LCI2.5% over 12 years (from the age 
of 6 years to 18 years). Thus, in our judgement, the age related changes in LCI and moment ratios are 
negligible. Therefore, we report fixed upper limits of normal during this age interval (Figure 2). 
 
The mean lower and upper limits of normal for LCI and moment ratios are provided in Table 2. The 
upper limit of normal for LCI2.5% was 7.91 and LCI5% was 5.73. Upper limits of normal for M1M0 was 





Functional residual capacity 
FRC values were right skewed and therefore natural log transformed FRC values and predictors were 
used in the models. Ln FRC was positively associated with ln height, weight, tidal volume, and age, 
and negatively associated with ln Vd/VT in the univariate analysis (Supplemental Table 1; Figure 3). 
There was no evidence of association with sex (p = 0.68) (Supplemental Table 1). In a multivariable 
model, ln FRC was independently associated with ln height and ln weight. There were no differences 
in FRC z-scores between centres (p = 0.81). The full FRC prediction equation including the intercept 
for the model is provided in the online supplement. 
 
Equation 1: FRC is expressed in L, height in cm, and weight in kg. 
 
DISCUSSION 
We report N2MBW normative data for a pediatric Caucasian population between the age of six and 18 
years using commercially available equipment and software. While a significant age dependency was 
observed for LCI and moment ratio outcomes, the magnitude of this effect was small during the age 
interval of 12 years. Therefore, fixed upper limits of normal for LCI and moment ratios can be used in 
this age group. FRC was independently predicted by both height and weight, and we provide FRC 
predicted values and z-score equation. 
 
Comparison with the literature 
The LCI2.5%  values in our cohort are slightly higher than previously reported for this age group [16, 
17, 24]. However, it is difficult to perform a direct comparison with previous studies due to 
differences in equipment and software algorithms. Lum and colleagues reported an ULN for LCI2.5% of 
7.53 in healthy children who performed MBW measurements using a mass-spectrometer with sulfur 
hexafluoride (SF6) as the tracer gas [17]. However, several studies have reported higher LCI2.5% values 
 
 
in N2MBW compared with SF6MBW [18, 32, 33]. These differences may be explained by different 
distribution of a resident gas compared with an exogenous gas in the lung tissue and/or by the 
contribution of N2 diffusion from the lung tissue during the washout [18, 20]. Fuchs and colleagues 
reported an ULN for LCI2.5% of 7.0 in healthy children who performed SF6MBW using a device which 
utilizes a similar ultrasonic flowmeter measurement principle [16]. Recent data show that this device 
provides lower LCI2.5%  values compared to the device used in our study [19, 34]. In addition, Houltz 
and colleagues [24]  reported an ULN for LCI2.5%  of 7.09 in healthy children who performed N2MBW 
using the same equipment used in our study but they analysed their data using a custom-made 
software, so a direct comparison between the two datasets is not possible. These findings highlight the 
need for equipment and software specific normative data for MBW data.  
 
Center differences 
Slight differences in height and weight between centers were not surprising because the age 
distribution of the study participants differed between centers. Previous multi-center studies have 
reported differences in MBW indices using the same measuring equipment and protocol [17, 35]. In 
order to minimize the risk for between-center differences, the analysis was performed using the same 
software version, system settings, and equipment related dead space. We did not find any differences 
in LCI and moment ratio outcomes between centers. Small but statistically significant differences were 
found in FRC between centers. However, FRC z-scores were not different between centers. Therefore 
we hypothesize that any differences in FRC between centers were simply due to differences in 
demographic data. 
 
Predictors of MBW outcomes 
Previous studies have reported that LCI2.5% is age-dependent from birth to adulthood [17, 25], however 
it is unclear whether this age-dependence continues during school-age and adolescence. Lum and 
colleagues reported that despite a small continuation of decline in LCI2.5%  throughout the entire 
pediatric range, changes were minimal once the child reached six years of age [17]. The authors 
reported that fixed upper limits of normal for LCI2.5%  could be used between the age of six and 19 
 
 
years. We report small but statistically significant associations between age and LCI and moment 
ratios. However, the changes in LCI and moment ratios with age during the school-age period are 
minimal as shown in Figure 2, therefore we believe that upper limits of normal for LCI and moment 
ratios are appropriate throughout this age range. 
 
We found that both height and weight independently predicted FRC in our cohort. This contrasts with 
data from Lum and colleagues who found that height, age, and sex were independent predictors of 
FRC in their cohort, however, the age range of their population extended from infancy to adolescence 
[17]. During the period from early childhood to adolescence, pubertal changes can result in higher 
variability in weight with increasing height. Therefore pubertal changes during this period likely 
influenced the association between FRC and weight, which appears to be independent of sex. Only 
seven out of 180 subjects in our study were classified as obese (≥ 2 body mass index z-scores) and 
therefore, it is possible that predicted FRC values could be underestimated in obese individuals.  
 
Technical and physiological factors 
In order to further understand the technical and physiological factors that may influence ventilation 
distribution outcome during childhood and adolescence, we investigated whether equipment related 
dead space and breathing pattern influenced results. It has been reported previously that Vd/VT 
decreases with age during childhood [36] and Vd/VT is positively associated with LCI outcomes [30]. 
We also found that Vd/VT was positively associated with LCI and moment ratio outcomes. Users can 
ensure that the effect of Vd on MBW outcomes is minimized by using the appropriate dead space 
reducers recommended by the manufacturer. In addition, manufacturers of MBW devices should aim 
to further reduce equipment related dead space to avoid over-estimation of ventilation distribution 
outcomes in young children [13].  
 
It has previously been shown that breathing pattern can influence MBW outcomes. Fixed 1L breathing 
protocols highly influenced LCI outcomes in children compared with relaxed breathing [29]. We 
found that the VT/FRC ratio was negatively associated with age and positively associated with 
 
 
ventilation distribution outcomes. These findings indicate that any small age-dependence of ventilation 
distribution outcomes in our study were likely to be influenced by age-dependent changes in Vd/VT 
and VT/FRC during the period from early childhood to adolescence. 
 
Strengths and limitations 
This study comprises the largest sample of healthy Caucasian children collected using a commercially 
available MBW device. All four centers have extensive experience in MBW testing and collected 
MBW data using the same equipment and measurement protocol. In addition, all the measurements 
were quality controlled and analysed using the same software version, equipment dead space volume, 
and system settings. However, the sample size is still relatively small for the generation of reference 
values. The quality control has been performed by a single operator, which could have produced a bias 
in the study. We did not report phase III slope indices as these estimates require additional breath-by-
breath quality control, which is not yet standardised. We did not include preschool children in this 
cohort for several reasons, including the limited number of preschool visits available in our data set, 
lack of preschool MBW standardization at the time of measurement, and differences in interfaces used 
for testing at this age (facemask vs mouthpiece). 
 
Recommendations for the use of reference values 
MBW outcomes are considered to be device and tracer gas specific [18-20, 37], thus these reference 
values have been generated for N2MBW data collected on the Eco Medics Exhalyzer D device.  It is 
possible that the upper limits of normal we report for LCI and moment ratios are appropriate for other 
MBW systems but further work is needed to address this. Our data were analysed using the Spiroware 
software version 3.2.1 which uses different signal processing algorithms compared with previous 
versions (described in the online supplement) which have known influences on outcomes [21, 37]. 
Ideally, the most robust approach for Spiroware users would be to reload their raw data (A-files) 
collected in previous software versions into the new software version in order to reanalyze them. If 
this is not feasible, the users should recruit age-matched healthy controls at their own centre. In 
addition, as we only included subjects of Caucasian origin and it is unclear whether MBW indices 
 
 
differ with ethnicity at this age range [17, 38], we cannot generalize these data to other ethnic groups. 
Future studies that include children of other ethnicities are needed. 
 
Conclusion 
This study provides reference values for N2MBW outcomes in Caucasian school-aged children 
measured on the commercially available Eco Medics AG ultrasonic flowmeter device. Definition of 
the upper limits of normal over a wide age range will allow appropriate interpretation of MBW 
outcomes in the pediatric clinical setting. 
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Table 1: Demographic and anthropometric characteristics of the study population per center. Data are 
presented as mean (SD). BMI: Body Mass Index; FRC: functional residual capacity. Weight, height 
and BMI z-scores were calculated according to CDC growth charts [39].   
 Bern Toronto Heidelberg Perth Total 
Subjects (males) 82 (38) 28 (19) 33 (20) 37 (15) 180 (92) 
No of trials 224 98 86 84 492 
Age, years 10.8 (3.8) 12.5 (3.1) 12.0 (2.6) 9.5 (2.0) 11.0 (3.3) 
Weight, kg 39.8 (17.0) 47.5 (15.5) 43.1 (16.0) 34.2 (10.4) 40.5 (15.9) 
Weight, z-score 0.21 (0.83) 0.34 (0.93) 0.01 (1.02) 0.27 (0.77) 0.21 (0.87) 
Height, cm 144.8 (21.9) 155.9 (17.8) 148.5 (14.6) 139.1 (12.8) 146.0 (19.1) 
Height, z-score 0.40 (1.00) 0.69 (1.40) -0.10 (1.06) 0.51 (0.69) 0.38 (1.05) 
BMI 18.0 (3.2) 19.0 (3.6) 19.0 (2.8) 17.3 (2.7) 18.2 (3.1) 
BMI, z-score 0.09 (0.90) 0.19 (1.03) 0.25 (1.20) 0.04 (0.83) 0.12 (0.97) 
FRC, L 1.77 (0.89) 2.19 (0.87) 1.78 (0.62) 1.50 (0.38) 1.78 (0.78) 
 
 
 Mean (SD) LLN ULN 
Within-test intra-subject 
variability, % (SD) 
LCI2.5% 7.04 (0.45) 6.16 7.91 4.77 (3.16) 
LCI5% 5.10 (0.32) 4.47 5.73 4.47 (2.89) 
M1/M0 1.58 (0.09) 1.40 1.75 4.10 (2.67) 
M2/M0 4.97 (0.60) 3.79 6.15 8.07 (5.22) 
 
Table 2: Mean (SD) values, upper limit of normal (ULN), lower limit of normal (LLN), and intra-
subject variability (SD) in multiple breath nitrogen washout outcomes from 180 healthy children. 
LCI2.5% and LCI5% = Lung clearance index at 2.5% and 5% of the initial nitrogen concentration, 
respectively. M1/M0 = moment ratio 1 and M2/M0 = moment ratio 2. ULN and LLN were calculated as 
mean ± 1.96SD. The intra-subject variability was calculated as % difference [(trial1-trial2)/mean%] 














Figure 1: Flow chart of healthy subjects who participated in the study. 
Figure 2: Relationship between age and lung clearance index at 2.5% (LCI2.5%), lung clearance index 
at 5% (LCI5%), moment ratio 1 (M1/M0), and moment ratio 2 (M2/M0). Dashed lines indicate upper 
limit of normal. 
















Normative data for multiple breath washout outcomes in school-aged Caucasian children 
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Each subject was tested in a single visit and performed at least two trials. During the test the child sat 
in an upright position wearing a nose-clip and was asked to breath regularly through a snorkel-like 
mouthpiece connected to a bacterial filter (Air Safety Eco Slimline, No. 4222/01), spirette, and dead 
space reducer (set 2 for subjects ≤35 kg, set 3 for subjects >35 kg). The washout was stopped 




The original temperature and pressure conditions were applied to the data and the software corrected 
appropriately for equipment-related dead space. The pre-capillary dead space was 33.3 ml for all 
measurements collected with both set 2 and set 3 29. The post-capillary dead space was either 9.5 ml 
for set 2 (children up to 35kg) or 22 ml for set 3 (children greater than 35kg). 
 
Differences in the analysis between Spiroware 3.1.6 and Spiroware 3.2.1 
The open-circuit hardware we used for N2MBW (Exhalyzer D, Eco Medics AG, Duernten, 
Switzerland) measures FN2 indirectly based on Dalton’s law 
E1. A side-stream oxygen (O2) sensor and 
a mainstream carbon dioxide (CO2) sensor measure gas concentrations. These two signals must be 
aligned in order to allow the calculation of the N2 signal. A static synchronization method has been 
used in previous software versions including Spiroware version 3.1.6 E1. During a measurement, flow, 
O2, and CO2 signals are not stable throughout the measurement and depend on the breathing pattern of 
the subject. Spiroware version 3.2.1 constantly calculates new delay times based on the breathing 
pattern (dynamic delay correction, DDC) E2. 
 
Apart from the different synchronization method, the calculation method of the re-inspired N2 volume 
differs also between the two software versions. In Spiroware 3.1.6 this is calculated from the post-
capillary dead space (number of breaths x post-capillary dead space) E3, while Spiroware 3.2.1 uses the 





Reloading measurements in Spiroware 3.2.1 
To ensure that our data were analyzed using the new DDC synchronization method we reloaded the 
raw data (recorded in Spiroware 3.1.6) into Spiroware 3.2.1. First, we performed a new 
synchronization of the signals by reloading the raw data (A-files) from one measurement per subject 
into the channel synchronization tool in Spiroware. Five consecutive breaths of good quality from the 
pre-washout phase were used to generate new static delay times. Each trial was then reloaded 
manually into Spiroware 3.2.1 to ensure calculation of the DDC was applied. The quality of the signal 
alignment was checked by visual control. The original temperature and pressure conditions were 
applied to the data and the software corrected appropriately for equipment-related dead space. 
 
Quality control of MBW trials 
The following criteria were used to assess quality of the entire dataset of MBW measurements after 
reloading in SPW 3.2.1: no evidence of a leak, stable pre-washout phase, regular breathing pattern 
during the washout, and at least three consecutive breaths with the end tidal concentration of N2 below 
2.5% of the pre-washout phase N2 concentration
E3. In addition, trials with a drift in end tidal CO2 
concentration out of the range of 4-6% across the washout were excludedE5. Tests with at least two 





The full regression equation for FRC is given below. The standard deviation of the residuals for the 
model was 0.1632. 





Univariate Analysis Coefficient 95% Confidence interval p-value 
LCI2.5%    
Height (cm) -0.0053 -0.0087; -0.0019 0.002 
Weight (kg) -0.0049 -0.0090; -0.0008 0.020 
Age (y) -0.0225 -0.0421; -0.0030 0.024 
Vd/VT (%) 0.0258 0.0093; 0.0422 0.002 
VT/FRC (%) 0.0040 -0.0013; 0.0093 0.135 
Sex 0.1413 -0.0113; 0.2712 0.133 
LCI5%    
Height (cm) -0.0046 -0.0070; -0.0023 <0.001 
Weight (kg) -0.0040 -0.0069; -0.0011 0.007 
Age (y) -0.0178 -0.0316; -0.0039 0.012 
Vd/VT (%) 0.0160 0.0042; 0.0278 0.008 
VT/FRC (%) 0.0073 0.0037; 0.0109 <0.001 
Sex 0.0867 -0.0058; 0.1796 0.066 
M1/M0    
Height (cm) -0.0009 -0.0016; -0.0002 0.009 
Weight (kg) -0.0008 -0.0016; 0.0002 0.060 
Age (y) -0.0030 -0.0069; 0.0009 0.133 
Vd/VT (%) 0.0050 0.0017; 0.0083 0.003 
VT/FRC (%) 0.0010 -0.0001; 0.0020  0.069 
Sex 0.0274 -0.0015; 0.0532 0.382 
M2/M0    
Height (cm) -0.0068 -0.0114; -0.0023 0.003 
Weight (kg) -0.0058 -0.0114; -0.0003 0.040 
Age (y) -0.0249 -0.0514; 0.0016 0.065 
Vd/VT (%)  0.0161 -0.0066; 0.03871 0.164 
VT/FRC (%) 0.0147 0.0079; 0.0215 <0.001 
Sex 0.1475 -0.02858; 0.3236 0.100 
Ln FRC (L)    
Ln Height (cm) 3.0997 2.9136; 3.286 <0.001 
Ln Weight (kg) 0.9668 0.8778; 1.0558 <0.001 
Ln Age (y) 1.1836 1.0857; 1.2814 <0.001 
Ln Vd/VT (%) -0.6429 -0.8042; -0.4815 <0.001 
Ln VT (L) 0.6918 0.5694; 0.8142 <0.001 
Sex -0.0270 -0.1580; 0.1039 0.684 
 
 
Supplemental Table 1: Univariate linear regression model describing the association between lung 
clearance index at 2.5% (LCI2.5%) and 5% (LCI5%), moment ratios 1 (M1/M0) and 2 (M2/M0), and 
functional residual capacity (FRC) with demographic and physiological parameters. VT/FRC (%): tidal 





Supplemental Table 2: Final multiple linear regression model describing the association between 
lung clearance index at 2.5% (LCI2.5%) and 5% (LCI5%), moment ratios 1 (M1/M0) and 2 (M2/M0), and 
functional residual capacity (FRC) with demographic and physiological parameters. VT/FRC (%): tidal 




Multivariate Analysis Coefficient 95% Confidence interval p-value 
LCI2.5%    
Age (y) 0.04 0.01; 0.07 0.02 
Vd/VT (%) 0.07 0.04; 0.10 <0.001 
VT/FRC (%) 0.02 0.01; 0.02 <0.001 
LCI5%    
Age (y) 0.04 0.02; 0.06 <0.001 
Vd/VT (%) 0.07 0.05; 0.08 <0.001 
VT/FRC (%) 0.02 0.01; 0.02 <0.001 
M1/M0    
Age (y) 0.01 0.01; 0.02 <0.001 
Vd/VT (%) 0.02 0.01; 0.02 <0.001 
VT/FRC (%) 0.004 0.00; 0.005 <0.001 
M2/M0    
Age (y) 0.07 0.03; 0.10 <0.01 
Vd/VT (%) 0.10 0.06; 0.14 <0.001 
VT/FRC (%) 0.03 0.02; 0.04 <0.001 
Ln FRC (L)    
ln Height (cm) 3.98 3.43; 4.54 <0.001 




Supplemental Figure 1: Distribution of age, height, lung clearance index at 2.5% (LCI2.5%) and 









Supplemental Figure 2: Association of Vd/VT (%) and VT/FRC (%) with age, and association of LCI 
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